Letters to the Editor: Two different doses and duration schedules of somatostatin -14 in the treatment of patients with bleeding oesophageal varices: a non-randomised controlled study
- 31 January 2000
- journal article
- other
- Published by Elsevier in Journal of Hepatology
- Vol. 32 (1), 171-172
- https://doi.org/10.1016/s0168-8278(00)80206-8
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosisJournal of Hepatology, 1998
- Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trialThe Lancet, 1997
- Sclerotherapy with or without Octreotide for Acute Variceal BleedingNew England Journal of Medicine, 1995
- Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysisBMJ, 1995
- Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleedingGastroenterology, 1990
- A Multicenter, Randomized, Double–Blind Trial of Somatostatin in the Management of Acute Hemorrhage From Esophageal VaricesHepatology, 1989